Lv5
868 积分 2024-10-16 加入
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
2小时前
已完结
Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
5小时前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
13天前
已完结
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)
18天前
已完结
CDR grafting and site-directed mutagenesis approach for the generation and affinity maturation of Anti-CD20 nanobody
1个月前
已完结
The landscape of CAR-engineered innate immune cells for cancer immunotherapy
1个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
1个月前
已完结
Strategies to overcome the challenges of low or no expression of heterologous proteins in Escherichia coli
1个月前
已完结
Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial
1个月前
已完结
Advances in antibody-based therapy in oncology
2个月前
已完结
皖公网安备34019202002308
